Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

BLT, ? 3.3mm NC, SLActive? 12 mm, Roxoli: medical device reports filed with FDA

470 reports name it, 2019–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

470
device reports naming the brand
0% of all MAUDE reports · about 69 a year
46
reports, 12 months to August 2026
43 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

470 medical device reports received by FDA name the brand "BLT, ? 3.3mm NC, SLActive? 12 mm, Roxoli" (endosseous dental implant); the manufacturer given most often on reports is Institut Straumann; received from September 2019 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

46 reports arrived in the 12 months to August 2026, close to the 43 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (86.8%), loss of osseointegration (8.5%) and separation failure (1.3%). The patient problems coded most often are fibrosis, tissue damage and pain. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

0917Sep 2021: 4Oct 2021: 7Nov 2021: 12Dec 2021: 32022Jan 2022: 16Feb 2022: 6Mar 2022: 2Apr 2022: 2May 2022: 8Jun 2022: 6Jul 2022: 10Aug 2022: 1Sep 2022: 1Oct 2022: 6Nov 2022: 4Dec 2022: 62023Jan 2023: 1Feb 2023: 7Mar 2023: 7Apr 2023: 9May 2023: 12Jun 2023: 10Jul 2023: 2Aug 2023: 5Sep 2023: 3Oct 2023: 17Nov 2023: 3Dec 2023: 92024Jan 2024: 3Feb 2024: 4Mar 2024: 5Apr 2024: 7May 2024: 7Jun 2024: 1Jul 2024: 3Aug 2024: 5Sep 2024: 2Oct 2024: 4Nov 2024: 5Dec 2024: 32025Jan 2025: 2Feb 2025: 4Mar 2025: 6Apr 2025: 0May 2025: 0Jun 2025: 9Jul 2025: 4Aug 2025: 4Sep 2025: 10Oct 2025: 1Nov 2025: 4Dec 2025: 72026Jan 2026: 3Feb 2026: 0Mar 2026: 8Apr 2026: 2May 2026: 1Jun 2026: 5Jul 2026: 1Aug 2026: 4

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

043852019: 5320192020: 7120202021: 6920212022: 6820222023: 8520232024: 4920242025: 5120252026: 242026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%470
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report89.6%421
Voluntary report0%0
User facility report0%0
Distributor report10.4%49
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate40886.8%62.8%
Loss of osseointegration408.5%22.4%
Separation failure61.3%0.1%
Difficult to insertthe device was hard to insert51.1%0.4%
Fracturea broken bone40.9%1.6%
Unintended movement10.2%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis13027.7%
Tissue damage9319.8%
Painpain, site not specified8518.1%
Inflammationinflammation459.6%
Hemorrhage/blood loss/bleeding245.1%
Fistula204.3%
Swelling/ edema173.6%
Abscessa collection of pus153.2%
Hyperresponsive to stimuli143%
Failure of implant61.3%
Increased sensitivity30.6%
Swellingswelling30.6%
Hypersensitivity/allergic reaction20.4%
Inadequate osseointegration10.2%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureBLT, ? 3.3mm NC, SLActive? 12 mm, RoxoliProduct code DZEAll MAUDE reports
Reports4703,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer89.6%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about BLT, ? 3.3mm NC, SLActive? 12 mm, Roxoli reports

How many FDA reports name BLT, ? 3.3mm NC, SLActive? 12 mm, Roxoli?

470 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 46 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (86.8%), loss of osseointegration (8.5%), separation failure (1.3%), difficult to insert (1.1%) and fracture (0.9%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (89.6%) and distributor reports (10.4%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that BLT, ? 3.3mm NC, SLActive? 12 mm, Roxoli was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.